Evidence map›Paper›PMID 25901056›Full record

ArticleJournal of oncology practice2015

Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.

Erin E Hahn, Tania Tang, Janet S Lee, Corrine Munoz-Plaza, Joyce O Adesina, Ernest Shen, Braden Rowley, Jared L Maeda, David M Mosen, John C Ruckdeschel and 1 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of oncology practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Erin E HahnKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR Erin.E.Hahn@kp.org.
Tania TangKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Janet S LeeKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Corrine Munoz-PlazaKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Joyce O AdesinaKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Ernest ShenKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Braden RowleyKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Jared L MaedaKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
David M MosenKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
John C RuckdeschelKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Michael K GouldKaiser Permanente Southern California, Pasadena; Southern California Permanente Medical Group, Los Angeles, CA; Intermountain Healthcare, Salt Lake City, UT; Mid-Atlantic Permanente Research Institute, Rockville, MD; and Kaiser Permanente Center for Health Research, Portland, OR.
Kaiser Permanente Center for Health Research · USKaiser Permanente · USIntermountain Healthcare · US

Funding

Mentored Training for Dissemination and Implemention Research in CancerR25CA171994 · NCI · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C · 2013 to 2017
$1.5M
NCI NIH HHS R25 CA171994
6 · The paper itself

Abstract

purposeAdvanced imaging is commonly used for staging of early-stage breast cancer, despite recommendations against this practice. The objective of this study was to evaluate and compare use of imaging for staging of breast cancer in two integrated health care systems, Kaiser Permanente (KP) and Intermountain Healthcare (IH). We also sought to distinguish whether imaging was routine or used for diagnostic purposes.

methodsWe identified patients with stages 0 to IIB breast cancer diagnosed between 2010 and 2012. Using KP and IH electronic health records, we identified use of computed tomography, positron emission tomography, or bone scintigraphy 30 days before diagnosis to 30 days postsurgery. We performed chart abstraction on a random sample of patients who received a presurgical imaging test to identify indication.

resultsFor the sample of 10,010 patients, mean age at diagnosis was 60 years (range, 22 to 99 years); with 21% stage 0, 47% stage I, and 32% stage II. Overall, 15% of patients (n = 1,480) received at least one imaging test during the staging window, 15% at KP and 14% at IH (P = .5). Eight percent of patients received imaging before surgery, and 7% postsurgery. We found significant intraregional variation in imaging use. Chart abstraction (n = 129, 16% of patients who received presurgical imaging) revealed that 48% of presurgical imaging was diagnostic.

conclusionUse of imaging for staging of low-risk breast cancer was similar in both systems, and slightly lower than has been reported in the literature. Approximately half of imaging tests were ordered in response to a sign or symptom.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsDelivery of Health Care, IntegratedDiagnostic ImagingElectronic Health RecordsFemaleGuideline AdherenceHealthcare DisparitiesHealth Maintenance OrganizationsHumansMammographyMiddle AgedNeoplasm StagingPositron-Emission Tomography

Identifiers

PMID25901056
PMCPMC5706143
OpenAlexW2204846279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.